The global hepatitis A virus cellular receptor 2 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Hepatitis A virus cellular receptor 2 (HAVCR2) is also known as T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). It is a protein that is encoded by the HAVCR2 (TIM-3)gene in humans. The major factor driving the demand for the global hepatitis A virus cellular receptor 2 market is the increasing prevalence of colon cancer across the globe. 

According to the American Society of Clinical Oncology (ASCO), in 2022, colorectal cancer is the third most diagnosed cancer globally with an estimated 151,030 adults will be diagnosed with colorectal cancer in the US.  Additionally, it includes 106,180 new cases of colon cancer including 54,040 cases in men and 52,140 cases in women and 44,850 new cases of rectal cancer with 26,650 in men and 18,200 in women. Furthermore, an estimated 1,880,725 people were diagnosed with colorectal cancer in 2020 which include 1,148,515 colon cancer cases and 732,210 rectal cancer cases.

Apart from this TIM-3 plays an important role in inhibiting T cell responses in both autoimmunity and cancer. Additionally, it interacts with the PD-1 pathway in the dysfunctional CD8+ T cells and Tregs in cancer. Hence, the increasing prevalence of cancer is driving the growth of the global hepatitis A virus cellular receptor 2 market during the forecast period. Moreover, North America is anticipated to hold a prominent share in the market owing to the significant prevalence of diseases such as cancer, and acute myeloid leukemia (AML), among others. Some major players in the market include BeiGene Ltd., Eli Lilly and Co., Novartis International AG, among others. 

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape-BeiGene Ltd., Eli Lilly and Co., and Novartis International AG, among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How players are addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Hepatitis A Virus Cellular Receptor 2 Market Report by Segment

By Type

• IMM-1802

• LY-3321367

• MCLA-134

• CA-170

• CA-327

• ENUM-005

• Others

By Application 

• Colon Cancer

• Myelodysplastic

• Non-Small Cell Lung Cancer

Global Hepatitis A Virus Cellular Receptor 2 Market Report by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa